Energy metabolism in the acquisition and maintenance of stemness

Seminars in Cell and Developmental Biology

Volumn 52, Issue , 2016, Pages 68-75

  Folmes, Clifford D L ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

Embryonic stem cells; Glycolysis; Hematopoietic stem cells; Induced pluripotent stem cells; Metabolic remodeling; Mitochondria; Nuclear reprograming; Oxidative metabolism

Indexed keywords

ADOPTION; CELL ENERGY; CELL FATE; CELL FUNCTION; DEVELOPMENTAL BIOLOGY; DNA TRANSCRIPTION; ENERGY METABOLISM; EPIGENETICS; GENETIC TRANSCRIPTION; IDENTITY; METABOLOMICS; REGENERATIVE MEDICINE; STEM CELL NICHE; TRANSCRIPTION REGULATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ENERGY METABOLISM; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84977865443     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2016.02.010     Document Type: Review

References (107)

1. Kaelin W.G., McKnight S.L. Influence of metabolism on epigenetics and disease. Cell 2013, 153:56-69.
2. Polo J.M., Anderssen E., Walsh R.M., Schwarz B.A., Nefzger C.M., Lim S.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151:1617-1632.
3. Cacchiarelli D., Trapnell C., Ziller M.J., Soumillon M., Cesana M., Karnik R., et al. Integrative analyses of human reprogramming reveal dynamic nature of induced pluripotency. Cell 2015, 162:412-424.
4. Hansson J., Rafiee M.R., Reiland S., Polo J.M., Gehring J., Okawa S., et al. Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep. 2012, 2:1579-1592.
5. Folmes C.D., Nelson T.J., Martinez-Fernandez A., Arrell D.K., Lindor J.Z., Dzeja P.P., et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011, 14:264-271.
6. Mathieu J., Zhou W., Xing Y., Sperber H., Ferreccio A., Agoston Z., et al. Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. Cell Stem Cell 2014, 14:592-605.
7. Prigione A., Rohwer N., Hoffmann S., Mlody B., Drews K., Bukowiecki R., et al. HIF1alpha modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2. Stem Cells 2014, 32:364-376.
8. Kida Y.S., Kawamura T., Wei Z., Sogo T., Jacinto S., Shigeno A., et al. ERRs mediate a metabolic switch required for somatic cell reprogramming to pluripotency. Cell Stem Cell 2015, 16:547-555.
9. Khaw S.L., Min-Wen C., Koh C.G., Lim B., Shyh-Chang N. Oocyte factors suppress mitochondrial polynucleotide phosphorylase to remodel the metabolome and enhance reprogramming. Cell Rep. 2015, 12:1080-1088.
10. Takashima Y., Guo G., Loos R., Nichols J., Ficz G., Krueger F., et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 2014, 158:1254-1269.
11. Zhou W., Choi M., Margineantu D., Margaretha L., Hesson J., Cavanaugh C., et al. HIF1alpha induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J. 2012, 31:2103-2116.
12. Sperber H., Mathieu J., Wang Y., Ferreccio A., Hesson J., Xu Z., et al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat. Cell Biol. 2015, 17:1523-1535.
13. Folmes C.D., Nelson T.J., Martinez-Fernandez A., Arrell D.K., Lindor J.Z., Dzeja P.P., et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011, 14:264-271.
14. Cho Y.M., Kwon S., Pak Y.K., Seol H.W., Choi Y.M., Park do J., et al. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 2006, 348:1472-1478.
15. Chung S., Dzeja P.P., Faustino R.S., Perez-Terzic C., Behfar A., Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(Suppl. 1):S60-S67.
16. Kondoh H., Lleonart M.E., Nakashima Y., Yokode M., Tanaka M., Bernard D., et al. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxid. Redox Signal 2007, 9:293-299.
17. Simsek T., Kocabas F., Zheng J., Deberardinis R.J., Mahmoud A.I., Olson E.N., et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010, 7:380-390.
18. Chen C.T., Shih Y.R., Kuo T.K., Lee O.K., Wei Y.H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008, 26:960-968.
19. Turner W.S., Seagle C., Galanko J.A., Favorov O., Prestwich G.D., Macdonald J.M., et al. Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels. Stem Cells 2008, 26:1547-1555.
20. Varum S., Rodrigues A.S., Moura M.B., Momcilovic O., Easley C.A., Ramalho-Santos J., et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 2011, 6:e20914.
21. Folmes C.D., Dzeja P.P., Nelson T.J., Terzic A. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 2012, 11:596-606.
22. Zhu S., Li W., Zhou H., Wei W., Ambasudhan R., Lin T., et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010, 7:651-655.
23. Yoshida Y., Takahashi K., Okita K., Ichisaka T., Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5:237-241.
24. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
25. Krizhanovsky V., Lowe S.W. Stem cells: the promises and perils of p53. Nature 2009, 460:1085-1086.
26. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
27. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
28. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460:1132-1135.
29. Utikal J., Polo J.M., Stadtfeld M., Maherali N., Kulalert W., Walsh R.M., et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 2009, 460:1145-1148.
30. Panopoulos A.D., Yanes O., Ruiz S., Kida Y.S., Diep D., Tautenhahn R., et al. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 2012, 22:168-177.
31. Ezashi T., Das P., Roberts R.M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4783-4788.
32. Mohyeldin A., Garzon-Muvdi T., Quinones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010, 7:150-161.
33. Varum S., Momcilovic O., Castro C., Ben-Yehudah A., Ramalho-Santos J., Navara C.S. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. Stem Cell Res. 2009, 3:142-156.
34. Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8:424-429.
35. Takubo K., Nagamatsu G., Kobayashi C.I., Nakamura-Ishizu A., Kobayashi H., Ikeda E., et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 2013, 12:49-61.
36. Prigione A., Lichtner B., Kuhl H., Struys E.A., Wamelink M., Lehrach H., et al. Human iPSCs harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining hESC-like metabolic reprogramming. Stem Cells 2011, 29:1338-1348.
37. Bustamante E., Pedersen P.L. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc. Natl. Acad. Sci. 1977, 74:3735-3739.
38. Suda T., Takubo K., Semenza G.L. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011, 9:298-310.
39. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
40. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54.
41. Ito K., Suda T. Metabolic requirements for the maintenance of self-renewing stem cells. Nat. Rev. Mol. Cell Biol. 2014, 15:243-256.
42. Perales-Clemente E., Folmes C.D., Terzic A. Metabolic regulation of redox status in stem cells. Antioxid. Redox Signal 2014, 21:1648-1659.
43. Takubo K., Goda N., Yamada W., Iriuchishima H., Ikeda E., Kubota Y., et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010, 7:391-402.
44. Miharada K., Karlsson G., Rehn M., Rorby E., Siva K., Cammenga J., et al. Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell 2011, 9:330-344.
45. Miharada K., Karlsson G., Rehn M., Rorby E., Siva K., Cammenga J., et al. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1alpha in the hypoxic bone marrow niche. Ann. N. Y. Acad. Sci. 2012, 1266:55-62.
46. Renault V.M., Rafalski V.A., Morgan A.A., Salih D.A., Brett J.O., Webb A.E., et al. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 2009, 5:527-539.
47. Pattappa G., Heywood H.K., de Bruijn J.D., Lee D.A. The metabolism of human mesenchymal stem cells during proliferation and differentiation. J. Cell Physiol. 2011, 226:2562-2570.
48. Pattappa G., Thorpe S.D., Jegard N.C., Heywood H.K., de Bruijn J.D., Lee D.A. Continuous and uninterrupted oxygen tension influences the colony formation and oxidative metabolism of human mesenchymal stem cell. Tissue Eng. Part C Methods 2013, 19:68-79.
49. Fischer B., Bavister B.D. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J. Reprod. Fertil. 1993, 99:673-679.
50. Forristal C.E., Wright K.L., Hanley N.A., Oreffo R.O., Houghton F.D. Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 2010, 139:85-97.
51. Powers D.E., Millman J.R., Huang R.B., Colton C.K. Effects of oxygen on mouse embryonic stem cell growth, phenotype retention, and cellular energetics. Biotechnol. Bioeng. 2008, 101:241-254.
52. Westfall S.D., Sachdev S., Das P., Hearne L.B., Hannink M., Roberts R.M., et al. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev. 2008, 17:869-881.
53. Mathieu J., Zhang Z., Nelson A., Lamba D.A., Reh T.A., Ware C., et al. Hypoxia induces re-entry of committed cells into pluripotency. Stem Cells 2013, 31:1737-1748.
54. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
55. Lunt S.Y., Vander Heiden M.G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 2011, 27:441-464.
56. Guppy M., Greiner E., Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem. 1993, 212:95-99.
57. Pfeiffer T., Schuster S., Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science 2001, 292:504-507.
58. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7:11-20.
59. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
60. Vander Heiden M.G., Locasale J.W., Swanson K.D., Sharfi H., Heffron G.J., Amador-Noguez D., et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329:1492-1499.
61. Hanover J.A., Krause M.W., Love D.C. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 2012, 13:312-321.
62. Jang H., Kim T.W., Yoon S., Choi S.Y., Kang T.W., Kim S.Y., et al. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012, 11:62-74.
63. Chou T.Y., Dang C.V., Hart G.W. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4417-4421.
64. Vella P., Scelfo A., Jammula S., Chiacchiera F., Williams K., Cuomo A., et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol. Cell 2013, 49:645-656.
65. Shi F.T., Kim H., Lu W., He Q., Liu D., Goodell M.A., et al. Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. J. Biol. Chem. 2013, 288:20776-20784.
66. Wellen K.E., Lu C., Mancuso A., Lemons J.M., Ryczko M., Dennis J.W., et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 2010, 24:2784-2799.
67. Lonergan T., Brenner C., Bavister B. Differentiation-related changes in mitochondrial properties as indicators of stem cell competence. J. Cell Physiol. 2006, 208:149-153.
68. Prigione A., Fauler B., Lurz R., Lehrach H., Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28:721-733.
69. Suhr S.T., Chang E.A., Tjong J., Alcasid N., Perkins G.A., Goissis M.D., et al. Mitochondrial rejuvenation after induced pluripotency. PLoS One 2010, 5:e14095.
70. Lonergan T., Bavister B., Brenner C. Mitochondria in stem cells. Mitochondrion 2007, 7:289-296.
71. Armstrong L., Tilgner K., Saretzki G., Atkinson S.P., Stojkovic M., Moreno R., et al. Human induced pluripotent stem cell lines show similar stress defence mechanisms and mitochondrial regulation to human embryonic stem cells. Stem Cells 2010, 28:661-673.
72. Facucho-Oliveira J.M., St John J.C. The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation. Stem Cell Rev. Rep. 2009, 5:140-158.
73. St John J.C., Ramalho-Santos J., Gray H.L., Petrosko P., Rawe V.Y., Navara C.S., et al. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells 2005, 7:141-153.
74. Yu W.M., Liu X., Shen J., Jovanovic O., Pohl E.E., Gerson S.L., et al. Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell 2013, 12:62-74.
75. Chen C., Liu Y., Liu R., Ikenoue T., Guan K.L., Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 2008, 205:2397-2408.
76. Norddahl G.L., Pronk C.J., Wahlestedt M., Sten G., Nygren J.M., Ugale A., et al. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 2011, 8:499-510.
77. Rimmele P., Liang R., Bigarella C.L., Kocabas F., Xie J., Serasinghe M.N., et al. Mitochondrial metabolism in hematopoietic stem cells requires functional FOXO3. EMBO Rep. 2015, 16:1164-1176.
78. San Martin N., Cervera A.M., Cordova C., Covarello D., McCreath K.J., Galvez B.G. Mitochondria determine the differentiation potential of cardiac mesoangioblasts. Stem Cells 2011, 29:1064-1074.
79. Ma T., Li J., Xu Y., Yu C., Xu T., Wang H., et al. Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming. Nat. Cell Biol. 2015, 17:1379-1387.
80. Facucho-Oliveira J.M., Alderson J., Spikings E.C., Egginton S., St John J.C. Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J. Cell Sci. 2007, 120:4025-4034.
81. Todd L.R., Damin M.N., Gomathinayagam R., Horn S.R., Means A.R., Sankar U. Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol. Biol. Cell 2010, 21:1225-1236.
82. Katajisto P., Dohla J., Chaffer C.L., Pentinmikko N., Marjanovic N., Iqbal S., et al. Stem cells: asymmetric apportioning of aged mitochondria between daughter cells is required for stemness. Science 2015, 348:340-343.
83. Prigione A., Hossini A.M., Lichtner B., Serin A., Fauler B., Megges M., et al. Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One 2011, 6:e27352.
84. Mah N., Wang Y., Liao M.C., Prigione A., Jozefczuk J., Lichtner B., et al. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network. PLoS One 2011, 6:e24351.
85. Zhang J., Khvorostov I., Hong J.S., Oktay Y., Vergnes L., Nuebel E., et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 2011, 30:4860-4873.
86. Mattenberger Y., James D.I., Martinou J.C. Fusion of mitochondria in mammalian cells is dependent on the mitochondrial inner membrane potential and independent of microtubules or actin. FEBS Lett. 2003, 538:53-59.
87. Teslaa T., Teitell M.A. Pluripotent stem cell energy metabolism: an update. EMBO J. 2015, 34:138-153.
88. Shyh-Chang N., Zheng Y., Locasale J.W., Cantley L.C. Human pluripotent stem cells decouple respiration from energy production. EMBO J. 2011, 30:4851-4852.
89. Sukumar M., Liu J., Mehta G.U., Patel S.J., Roychoudhuri R., Crompton J.G., et al. Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy. Cell Metab. 2015, 23:63-76.
90. Schieke S.M., Ma M., Cao L., McCoy J.P., Liu C., Hensel N.F., et al. Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J. Biol. Chem. 2008, 283:28506-28512.
91. Wellen K.E., Thompson C.B. A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:270-276.
92. Moussaieff A., Rouleau M., Kitsberg D., Cohen M., Levy G., Barasch D., et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 2015, 21:392-402.
93. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
94. Bracha A.L., Ramanathan A., Huang S., Ingber D.E., Schreiber S.L. Carbon metabolism-mediated myogenic differentiation. Nat. Chem. Biol. 2010, 6:202-204.
95. Oburoglu L., Tardito S., Fritz V., de Barros S.C., Merida P., Craveiro M., et al. Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification. Cell Stem Cell 2014, 15:169-184.
96. Folmes C.D., Terzic A. Stem cell lineage specification: you become what you eat. Cell Metab. 2014, 20:389-391.
97. Carey B.W., Finley L.W., Cross J.R., Allis C.D., Thompson C.B. Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 2015, 518:413-416.
98. Wang J., Alexander P., Wu L., Hammer R., Cleaver O., McKnight S.L. Dependence of mouse embryonic stem cells on threonine catabolism. Science 2009, 325:435-439.
99. Alexander P.B., Wang J., McKnight S.L. Targeted killing of a mammalian cell based upon its specialized metabolic state. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15828-15833.
100. Han C., Gu H., Wang J., Lu W., Mei Y., Wu M. Regulation of L-threonine dehydrogenase in somatic cell reprogramming. Stem Cells 2013, 31:953-965.
101. Shyh-Chang N., Locasale J.W., Lyssiotis C.A., Zheng Y., Teo R.Y., Ratanasirintrawoot S., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013, 339:222-226.
102. Shiraki N., Shiraki Y., Tsuyama T., Obata F., Miura M., Nagae G., et al. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab. 2014, 19:780-794.
103. Ito K., Carracedo A., Weiss D., Arai F., Ala U., Avigan D.E., et al. A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat. Med. 2012, 18:1350-1358.
104. Knobloch M., Braun S.M., Zurkirchen L., von Schoultz C., Zamboni N., Arauzo-Bravo M.J., et al. Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis. Nature 2013, 493:226-230.
105. Folmes C.D., Park S., Terzic A. Lipid metabolism greases the stem cell engine. Cell Metab. 2013, 17:153-155.
106. Kreipke R., Wangb Y., Miklas J.W., Mathieu J., Ruohola-Baker H. Metabolic remodeling in early development and cardiomyocyte maturation. Semin. Cell Dev. Biol. 2016, 10.1016/j.semcdb.2016.02.004.
107. St.John J.C. Mitochondrial DNA copy number and replication in reprogramming and differentiation. Semin. Cell Dev. Biol. 2016, 10.1016/j.semcdb.2016.01.028.